Bavarian Nordic

Company snapshot

Bavarian Nordic A/S is a Danish [biotechnology](en.wikipedia.org/wiki/Biotechnology) company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in [Hellerup](en.wikipedia.org/wiki/Hellerup), [Denmark](en.wikipedia.org/wiki/Denmark), with manufacturing facilities in [Kvistgård](en.wikipedia.org/wiki/Kvistg%C3%A5rd), Denmark and [Thörishaus](en.

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 25 US patent(s) indexed to this assignee profile.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Bavarian Nordic. Not investment advice.

• What is Bavarian Nordic?

  Bavarian Nordic A/S is a pharma organization headquartered in HELLERUP, DK. Primary therapeutic focus areas include Chikungunya Virus. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, an

• Is Bavarian Nordic publicly traded?

  Bavarian Nordic appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Bavarian Nordic develop or market?

  We link 1 drug profile(s) where Bavarian Nordic is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/bavarian-nordic-a-s#company-drugs.

• What are the latest developments for Bavarian Nordic?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Bavarian Nordic focus on?

  Bavarian Nordic focuses on Chikungunya Virus based on our analysis of their pipeline programs and drug development activities.